These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25458423)

  • 1. Autonomic responses to exercise: group III/IV muscle afferents and fatigue.
    Amann M; Sidhu SK; Weavil JC; Mangum TS; Venturelli M
    Auton Neurosci; 2015 Mar; 188():19-23. PubMed ID: 25458423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group III/IV muscle afferents limit the intramuscular metabolic perturbation during whole body exercise in humans.
    Blain GM; Mangum TS; Sidhu SK; Weavil JC; Hureau TJ; Jessop JE; Bledsoe AD; Richardson RS; Amann M
    J Physiol; 2016 Sep; 594(18):5303-15. PubMed ID: 27241818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the Influence of Group III/IV Muscle Afferent Feedback on Endurance Exercise Performance.
    Amann M; Wan HY; Thurston TS; Georgescu VP; Weavil JC
    Exerc Sport Sci Rev; 2020 Oct; 48(4):209-216. PubMed ID: 32658041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Group III and IV muscle afferents for the endurance exercising human.
    Amann M
    Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):831-5. PubMed ID: 22300329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue-related firing of muscle nociceptors reduces voluntary activation of ipsilateral but not contralateral lower limb muscles.
    Kennedy DS; Fitzpatrick SC; Gandevia SC; Taylor JL
    J Appl Physiol (1985); 2015 Feb; 118(4):408-18. PubMed ID: 25525208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ensemble Input of Group III/IV Muscle Afferents to CNS: A Limiting Factor of Central Motor Drive During Endurance Exercise from Normoxia to Moderate Hypoxia.
    Amann M; Dempsey JA
    Adv Exp Med Biol; 2016; 903():325-42. PubMed ID: 27343106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological attenuation of group III/IV muscle afferents improves endurance performance when oxygen delivery to locomotor muscles is preserved.
    Hureau TJ; Weavil JC; Thurston TS; Wan HY; Gifford JR; Jessop JE; Buys MJ; Richardson RS; Amann M
    J Appl Physiol (1985); 2019 Nov; 127(5):1257-1266. PubMed ID: 31513446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oscillatory blood pressure response to the onset of cycling exercise in men: role of group III/IV muscle afferents.
    Barbosa TC; Fernandes IA; Magalhães N; Cavalcanti IL; Secher NH; Nóbrega AC; Vianna LC
    Exp Physiol; 2015 Mar; 100(3):302-11. PubMed ID: 25581883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral µ-opioid receptors attenuate the responses of group III and IV afferents to contraction in rats with simulated peripheral artery disease.
    Harms J; Stone AJ; Kaufman MP
    J Neurophysiol; 2018 Jun; 119(6):2052-2058. PubMed ID: 29465323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic control of the heart during exercise in humans: role of skeletal muscle afferents.
    Fisher JP
    Exp Physiol; 2014 Feb; 99(2):300-5. PubMed ID: 23995102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle reflex control of sympathetic nerve activity in heart failure: the role of exercise conditioning.
    Khan MH; Sinoway LI
    Heart Fail Rev; 2000 Mar; 5(1):87-100. PubMed ID: 16228918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans.
    Amann M; Blain GM; Proctor LT; Sebranek JJ; Pegelow DF; Dempsey JA
    J Physiol; 2011 Nov; 589(Pt 21):5299-309. PubMed ID: 21878520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic responses to exercise: cortical and subcortical responses during post-exercise ischaemia and muscle pain.
    Macefield VG; Henderson LA
    Auton Neurosci; 2015 Mar; 188():10-8. PubMed ID: 25458426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group III/IV muscle afferents impair limb blood in patients with chronic heart failure.
    Amann M; Venturelli M; Ives SJ; Morgan DE; Gmelch B; Witman MA; Jonathan Groot H; Walter Wray D; Stehlik J; Richardson RS
    Int J Cardiol; 2014 Jun; 174(2):368-75. PubMed ID: 24794967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging alters muscle reflex control of autonomic cardiovascular responses to rhythmic contractions in humans.
    Sidhu SK; Weavil JC; Venturelli M; Rossman MJ; Gmelch BS; Bledsoe AD; Richardson RS; Amann M
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1479-89. PubMed ID: 26386110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects.
    Pollak KA; Swenson JD; Vanhaitsma TA; Hughen RW; Jo D; White AT; Light KC; Schweinhardt P; Amann M; Light AR
    Exp Physiol; 2014 Feb; 99(2):368-80. PubMed ID: 24142455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between the effect of static contraction and tendon stretch on the discharge of group III and IV muscle afferents.
    Hayes SG; Kindig AE; Kaufman MP
    J Appl Physiol (1985); 2005 Nov; 99(5):1891-6. PubMed ID: 15994238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of hyperpnoea and pulmonary gas exchange during prolonged exercise: The role of group III/IV muscle afferent feedback.
    Iannetta D; Weavil JC; Laginestra FG; Thurston TS; Broxterman RM; Jenkinson RH; Curtis MC; Chang J; Wan HY; Amann M
    J Physiol; 2024 Oct; 602(20):5375-5389. PubMed ID: 39316014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group III and IV muscle afferents: role on central motor drive and clinical implications.
    Laurin J; Pertici V; Dousset E; Marqueste T; Decherchi P
    Neuroscience; 2015 Apr; 290():543-51. PubMed ID: 25659344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'sensory tolerance limit': A hypothetical construct determining exercise performance?
    Hureau TJ; Romer LM; Amann M
    Eur J Sport Sci; 2018 Feb; 18(1):13-24. PubMed ID: 27821022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.